Chairman of the Board and CEO of BioScrip Inc. (BIOS, Financial) Richard H Friedman sells 20,000 shares of BIOS on 12/08/2009 at an average price of $8.05 a share.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $313 million; its shares were traded at around $7.96 with a P/E ratio of 19 and P/S ratio of 0.2.
BIOS is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $313 million; its shares were traded at around $7.96 with a P/E ratio of 19 and P/S ratio of 0.2.
BIOS is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES.
Insiders' Positions with BIOS
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 10,000 shares of BIOS stock on 12/01/2009 at the average price of 7.69, the price of the stock has increased by 3.51% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 8,302 shares of BIOS stock on 11/16/2009 at the average price of 9, the price of the stock has decreased by 11.56% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 85,000 shares of BIOS stock on 11/09/2009 at the average price of 8.01, the price of the stock has decreased by 0.62% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 58,000 shares of BIOS stock on 11/04/2009 at the average price of 7.73, the price of the stock has increased by 2.98% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 7,861 shares of BIOS stock on 10/14/2009 at the average price of 7, the price of the stock has increased by 13.71% since
Insiders' Positions with BIOS
- Sell:: 10% Owner William J Nasgovitz sold 13,600 shares of BIOS stock on 12/01/2009 at the average price of 7.69, the price of the stock has increased by 3.51% since
- Sell:: 10% Owner William J Nasgovitz sold 62,000 shares of BIOS stock on 11/25/2009 at the average price of 7.78, the price of the stock has increased by 2.31% since
- Sell:: 10% Owner William J Nasgovitz sold 24,400 shares of BIOS stock on 11/23/2009 at the average price of 7.83, the price of the stock has increased by 1.66% since
- Sell:: Executive Vice President Thomas Ordemann sold 41,260 shares of BIOS stock on 11/11/2009 at the average price of 8.56, the price of the stock has decreased by 7.01% since
- Sell:: Executive Vice President Thomas Ordemann sold 41,260 shares of BIOS stock on 11/11/2009 at the average price of 8.56, the price of the stock has decreased by 7.01% since
